報價延遲最少15分鐘:2025/05/30 12:58 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
19.23 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.70/-3.54
|
|
企業價值
1.32B
|
| 資產負債 |
|
每股賬面淨值
10.59
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
7.02M
|
|
每股收益
0.07
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/30 12:58 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care. |